Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Bettina Ploder"'
Autor:
Bülent Zülfikar, Johnny Mahlangu, Salim Mohamed Nekkal, Cecil Ross, Noppacharn Uaprasert, Jerzy Windyga, Carmen Escuriola Ettingshausen, Bettina Ploder, Aurelia Lelli, Hanna T. Gazda
Publikováno v:
TH Open, Vol 08, Iss 03, Pp e273-e282 (2024)
Background Activated prothrombin complex concentrate (aPCC) is indicated for bleed treatment and prevention in patients with hemophilia with inhibitors. The safety and tolerability of intravenous aPCC at a reduced volume and faster infusion rates wer
Externí odkaz:
https://doaj.org/article/d6aef7dc90ac43e488c3d85c23242dd4
Autor:
Jerzy Windyga MD, PhD, Oleksandra Stasyshyn MD, PhD, Toshko Lissitchkov MD, PhD, Vasily Mamonov MD, PhD, Margit Serban MD, PhD, Luminita Rusen MD, PhD, Bettina Ploder MSc, Srilatha Tangada PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 26 (2020)
This phase 3, prospective, open-label, multicenter, continuation study (NCT01286779) investigated the use of a recombinant factor IX (FIX), nonacog gamma (BAX 326, RIXUBIS ® ) in patients with severe or moderately severe hemophilia B. The study popu
Externí odkaz:
https://doaj.org/article/53acbf307856414a98abc07531c9dfd7
Autor:
Bettina Ploder, Nina Schiestl, Edith Hantak, Hans Pistner, Wilfried Wagner, Miranda Chapman, Jörg Wiltfang, Murat Yildirim
Publikováno v:
Clinical Oral Implants Research. 23:1112-1117
Objectives The aim of this study was to evaluate the extent and quality of new bone 6 months after sinus lift with biphasic micro- and macroporous calcium phosphate combined with fibrin sealant (MBCP-FS) and the 1-year implant success rate in the aug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4a3e1625bd88835943ea56610fb7cda
https://doi.org/10.1111/j.1600-0501.2011.02275.x
https://doi.org/10.1111/j.1600-0501.2011.02275.x
Autor:
Bettina Ploder, James W. Dennis, Isabella Presch, Sibu P. Saha, Worthington G. Schenk, Satish C. Muluk, Andreas Goppelt, Ani Grigorian
Publikováno v:
Journal of Vascular Surgery. 56(1):134-141
ObjectiveThe ideal hemostatic agent for treatment of suture-line bleeding at vascular anastomoses has not yet been established. This study evaluated whether the use of a fibrin sealant containing 500 IU/mL thrombin and synthetic aprotinin (FS; market
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78e02d432b8f631b839b8c48f5adaa7f
Autor:
Sandra G. Burks, Bettina Ploder, Edith Hantak, Sibu P. Saha, Worthington G. Schenk, Satish C. Muluk, Ani Grigorian, Borislava G. Pavlova, Isabella Presch
Publikováno v:
Annals of Vascular Surgery. 25:813-822
Background The low thrombogenicity, porosity, and limited elasticity of expanded polytetrafluoroethylene (ePTFE) vascular grafts, although beneficial, may exacerbate the problem of suture-line bleeding at vascular anastomoses and consequently lead to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a98c6a945220287e85a21a9c438637f
https://doi.org/10.1016/j.avsg.2010.12.016
https://doi.org/10.1016/j.avsg.2010.12.016
Autor:
Edith Hantak, Borislava G. Pavlova, Sibu P. Saha, Bettina Ploder, Ani Grigorian, Isabella Presch, Sandra G. Burks, Satish C. Muluk, Worthington G. Schenk
Publikováno v:
Annales de Chirurgie Vasculaire. 25:867-877
Introduction Bien que benefique, la faible thrombogenicite, porosite et elasticite des protheses en polytetrafluoroethylene expanse (ePTFE) peut exacerber le probleme des saignements sur ligne de suture au niveau des anastomoses vasculaires et condui
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b283980de757c7d623a7f19933994a5
https://doi.org/10.1016/j.acvfr.2012.10.016
https://doi.org/10.1016/j.acvfr.2012.10.016
Autor:
Kevin, Foster, David, Greenhalgh, Richard L, Gamelli, David, Mozingo, Nicole, Gibran, Michael, Neumeister, Steven Zvi, Abrams, Edith, Hantak, Lisa, Grubbs, Bettina, Ploder, Neil, Schofield, Louis H, Riina, Chester, Paul
Publikováno v:
Journal of Burn Care & Research. 29:293-303
The objective of this phase 3, multicentered, prospective, randomized, evaluator-blinded, clinical study was to compare skin graft adherence utilizing a fibrin sealant containing 4 IU/ml thrombin (FS 4IU VH S/D [FS 4IU VH S/D will be marketed under t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6dd95205c495c43360ceccb4ba5e258
https://doi.org/10.1097/bcr.0b013e31816673f8
https://doi.org/10.1097/bcr.0b013e31816673f8
Publikováno v:
Langenbeck's archives of surgery. 399(7)
This randomized, controlled, single-blinded multicenter study evaluated the efficacy of latest-generation fibrin sealant containing synthetic aprotinin as fibrinolysis inhibitor as supportive treatment for hemostasis after elective partial hepatectom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61e21e9fde9cc99d4cb6047e0aeb0eb1
https://pubmed.ncbi.nlm.nih.gov/25037462
https://pubmed.ncbi.nlm.nih.gov/25037462